Table 1.
The characteristics of the subjects.
Tattoo/sex/age group | Total DRT (%) | Biomarker (pg/ml) |
Reference | Agea | ||
---|---|---|---|---|---|---|
Aβ42 | t-tau | pT231 | ||||
C2538/female/young | 68.09 | 655.10 | 301.60 | 2.36 | Darusman et al. (2013a) | 9 |
C0744/male/young | 60.50 | 620.00 | 568.60 | 6.27 | Darusman et al. (2013a) | 7 |
10063/female/memory-affected | 40.58 | 16.01 | 92.62 | 4.81 | Darusman et al. (2013b) | 30 |
T3311/male/memory-affected | 40.00 | 368.36 | 319.46 | 4.19 | Darusman et al. (2013a) | 30b |
I1112/female/memory-affected | 34.34 | 164.96 | 219.85 | 5.45 | Darusman et al. (2013a) | 29 |
10749/female/age-matched | 61.67 | 416.36 | 370.57 | 4.11 | Darusman et al. (2013b) | 30 |
9661/male/age-matched | 60.16 | 480.76 | 277.71 | 7.55 | Darusman et al. (2013b) | 27 |
T3283/male/age-matched | 66.42 | 524.65 | 60.64 | 4.37 | Darusman et al. (2013b) | 30b |
Data are collected from the references Darusman et al. (2013a,b). DRT performance is presented as the collected percent of trials where the subject could correctly retrieve a hidden item following a predetermined delay. Biomarker levels were measured in serum and CSF.
aUp to the end of year of 2013.
bEstimated from the year of birth by a population survey in 1983.